Back to search
FDAFDA · Food and drugs·Recall number Z-2171-2026

ZYMUTEST HIA IgG, in vitro diagnostic ELISA kit, Ref. RK040A

Published May 20, 2026 · Recall initiated: April 1, 2026

Summary

FDA records medical device Class II recall Z-2171-2026, published May 20, 2026 and initiated April 1, 2026. Recalling firm: Aniara Diagnostica LLC; Status: Ongoing; Reported quantity: 359 units; Lot: UDI-DI: 03663537018763; Lot Number: FD1265. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Kits from lot FD1265 had been packaged on 17 October 2024 and put on the market with an outdated flyer (8 October 2024), containing incorrect values for the positive control.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Aniara Diagnostica LLC
Distributor
US Nationwide distribution in the states of CA, GA, MN, MO, NC, NM, NY, VA, WA, and WI
Lot
UDI-DI: 03663537018763; Lot Number: FD1265
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was ZYMUTEST HIA IgG, in vitro diagnostic ELISA kit, Ref. RK040A recalled?

Yes. FDA published recall Z-2171-2026 on May 20, 2026. Reported hazard: Kits from lot FD1265 had been packaged on 17 October 2024 and put on the market with an outdated flyer (8 October 2024), containing incorrect values for the positive control.

What should I do if I have this product?

Voluntary: Firm initiated · Letter